These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 18587286)
1. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system. Zivin M; Pregelj P Psychiatr Danub; 2008 Jun; 20(2):168-73. PubMed ID: 18587286 [TBL] [Abstract][Full Text] [Related]
3. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Duysen EG; Li B; Darvesh S; Lockridge O Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease. García-Ayllón MS; Silveyra MX; Andreasen N; Brimijoin S; Blennow K; Sáez-Valero J J Neurochem; 2007 Jun; 101(6):1701-11. PubMed ID: 17326766 [TBL] [Abstract][Full Text] [Related]
7. Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease. Foldi NS; White RE; Schaefer LA Int J Geriatr Psychiatry; 2005 May; 20(5):485-8. PubMed ID: 15852461 [TBL] [Abstract][Full Text] [Related]
8. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine. Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689 [TBL] [Abstract][Full Text] [Related]
9. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Reale M; Iarlori C; Gambi F; Feliciani C; Isabella L; Gambi D Neuropharmacology; 2006 Apr; 50(5):606-13. PubMed ID: 16445950 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons. Kimura M; Akasofu S; Ogura H; Sawada K Brain Res; 2005 Jun; 1047(1):72-84. PubMed ID: 15893738 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Kroker KS; Rast G; Giovannini R; Marti A; Dorner-Ciossek C; Rosenbrock H Neuropharmacology; 2012 Apr; 62(5-6):1964-74. PubMed ID: 22245562 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Liang YQ; Tang XC Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892 [TBL] [Abstract][Full Text] [Related]
14. Donepezil for Alzheimer's disease. Benjamin B; Burns A Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. Kume T; Sugimoto M; Takada Y; Yamaguchi T; Yonezawa A; Katsuki H; Sugimoto H; Akaike A Eur J Pharmacol; 2005 Dec; 527(1-3):77-85. PubMed ID: 16313899 [TBL] [Abstract][Full Text] [Related]
16. The combination of donepezil and procyclidine protects against soman-induced seizures in rats. Haug KH; Myhrer T; Fonnum F Toxicol Appl Pharmacol; 2007 Apr; 220(2):156-63. PubMed ID: 17289099 [TBL] [Abstract][Full Text] [Related]
17. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562 [TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitor donepezil dilates cerebral parenchymal arterioles via the activation of neuronal nitric oxide synthase. Nakahata K; Kinoshita H; Hama-Tomioka K; Ishida Y; Matsuda N; Hatakeyama N; Haba M; Kondo T; Hatano Y Anesthesiology; 2008 Jul; 109(1):124-9. PubMed ID: 18580182 [TBL] [Abstract][Full Text] [Related]
19. The aryl acylamidase activity is much more sensitive to Alzheimer drugs than the esterase activity of acetylcholinesterase in chicken embryonic brain. Rajesh RV; Chitra L; Layer PG; Boopathy R Biochimie; 2009 Sep; 91(9):1087-94. PubMed ID: 19607873 [TBL] [Abstract][Full Text] [Related]
20. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Cachard-Chastel M; Devers S; Sicsic S; Langlois M; Lezoualc'h F; Gardier AM; Belzung C Behav Brain Res; 2008 Mar; 187(2):455-61. PubMed ID: 18061284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]